David Reese

Executive Vice President of Research and Development

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2024	Amgen Inc (AMGN)	CTO	$1,268,615	$0	$3,359,613	$1,439,984	$1,740,000	$318,610	$8,126,822
2023	Amgen Inc (AMGN)	CTO	$1,212,823	$0	$3,149,928	$1,349,985	$1,929,000	$260,919	$7,902,655
2022	Amgen Inc (AMGN)	CTO	$1,158,846	$0	$3,149,736	$1,349,995	$1,397,000	$277,547	$7,333,124

Retired Executive Vice President at Amgen Inc (AMGN)
2026-06-30
Retired Executive Vice President and Chief Technology Officer at Amgen Inc (AMGN)
2026-06-30